⚕️ HealthLine
AI
STAT+: Patient health data as a public utility: A former ARPA-H data chief explains
Calls for reform in social care and COVID-19 inquiry defense
Mar 5, 2026
Read →
⚕️
Health & Wellness
Healthcare, medicine, wellness, and health research
LIVE
20 stories
Topics: ⚕️ HealthLine
Latest in Health & Wellness (20)
⚕️ HealthLine
AI
STAT+: Pharmalittle: We’re reading about TrumpRx shortcomings, Lilly targeting employers, and more
From TrumpRx shortcomings to breakthroughs in Alzheimer's treatment and allergy awareness
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Healthcare in Crisis: Delays, Costs, and Systemic Issues Exposed
Reports highlight endometriosis diagnosis delays, FDA criticism, and social care struggles
Mar 5, 2026
Read →
⚕️ HealthLine
AI
UK Healthcare Under Strain Amid Long Waits and Funding Pressures
Investigation reveals 50,000 patients waited over 24 hours in A&E corridor care
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Healthcare System Flaws Exposed
Recent Developments Highlight Issues in Medicare, Medicaid, and Patient Care
Mar 5, 2026
Read →
⚕️ HealthLine
AI
FDA Doubts Efficacy of UniQure's Huntington's Therapy Amid AI Breakthroughs
Regulatory updates on AI chatbots, human embryo models, and public health movements
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Autism researchers rebuke Kennedy, form independent advisory group
Recent developments highlight the complex challenges facing the healthcare sector, from the ongoing impact of the pandemic to breakthroughs in gene editing and the plight of stranded cancer patients.
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Dentists return £900m for not seeing NHS patients
From NHS dentistry to AI-powered recruitment, the healthcare sector faces numerous challenges while embracing innovative solutions.
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Healthcare Under Scrutiny: Safety, Access, and Innovation
From AI to period poverty, medical malpractice to maternity services, the healthcare industry faces numerous challenges
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Can Medicine Solve the Toughest Health Mysteries?
Breakthroughs in genetics, addiction, and disease elimination offer new hope
Mar 5, 2026
Read →
⚕️ HealthLine
AI
Cigna Expands into Hospital Pharmacy Services
Acquisition of CarepathRx strengthens health insurer's grip on prescription drug market
Feb 26, 2026
Read →
⚕️ HealthLine
AI
Big Pharma Partners with Innovators to Tackle Chronic Diseases
Novo Nordisk and Merck team up with startups and hospitals to develop new treatments
Feb 25, 2026
Read →
⚕️ HealthLine
AI
FDA Rejects Rare Disease Drug, While Sperm Study Finds Seasonal Patterns
Summer boost to sperm quality and a top health official's hopes for prior authorization reform
Feb 25, 2026
Read →
⚕️ HealthLine
AI
Heart Disease to Affect 6 in 10 Women by 2050
A staggering 60% of women are projected to develop heart disease or stroke by 2050, according to a recent forecast by the heart association, signaling a growing health concern that demands attention.
Feb 25, 2026
Read →
⚕️ HealthLine
AI
Trump Highlights Lower Drug Costs in State of the Union
Efforts to reduce healthcare costs and combat fraud amid rising unaffordability concerns
Feb 25, 2026
Read →
⚕️ HealthLine
AI
GPs Must Guarantee Same-Day Appointments for Urgent Cases
New contract clause aims to ensure timely care for patients with pressing health needs
Feb 24, 2026
Read →
⚕️ HealthLine
AI
Novo's Obesity Drug Shows Promise as FDA Weighs Changes
New study results and regulatory developments in the pharmaceutical industry
Feb 24, 2026
Read →
⚕️ HealthLine
AI
What's the State of Global Health Amid War and Medical Breakthroughs?
As Ukraine's healthcare system faces unprecedented attacks, the global medical community is pushing the boundaries of preventative healthcare with AI-driven "digital twins" and grappling with the ethics of accepting donations from questionable sources.
Feb 24, 2026
Read →
⚕️ HealthLine
AI
NHS Innovations: Weight Loss and Womb Transplants
New initiatives and medical breakthroughs in the UK's National Health Service
Feb 24, 2026
Read →
⚕️ HealthLine
AI
Hims CEO Addresses Scrutiny of Compounded GLP-1s in Earnings Call
Hims & Hers CEO Andrew Dudum addressed increasing scrutiny of compounded GLP-1s, discussing the impact on the company's financials and future plans.
Feb 24, 2026
Read →